Purchase Order 75N93020P01094

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $14,337.00 on June 23, 2020, to supply fetal bovine serum, heat inactivated. Performance is based in Minneapolis, Minnesota, with an ultimate completion date of July 22, 2020. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for biomaterial on August 11, 2015, with a ceiling value of $34,000.00. Performance takes place in Grand Island, New York. The order is firm fixed price with an ultimate completion date of September 30, 2016.</p>

This is a $17,801.60 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the delivery of fetal bovine serum, a critical reagent used in biomedical research. This award does not utilize any set-aside designations. Life Technologies Corporation has a history of serving as a...

This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $7,560.00 contract is for the delivery of fetal bovine serum, ultra-low IgG, of U.S. origin. The award does not utilize any set-aside designations. Life Technologies is a division of the parent company Thermo...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the delivery of US Certified Heat Inactivated Fetal Bovine Serum. The contract has a completion date of September 29, 2017, a potential value of $9,360.00, and did not utilize any set-aside designations. Life...

This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation (doing business as Thermo Fisher Scientific) for the supply of fetal bovine serum. The contract has a ceiling value of $18,173.60 and is a firm-fixed-price purchase order with a completion date of December 31, 2024. The contract does not utilize a set-aside designation. Life Technologies...

This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,842.16 contract is for the delivery of Value Hi Fetal Bovine Serum, a critical biological material used in biomedical research. Life Technologies Corporation, a division of the parent company Thermo Fisher...

The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $26,208.00 purchase order contract to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the delivery of 80 bottles of US Origin Certified FBS (Fetal Bovine Serum), Cat. # 16000044 with a completion date of August 9, 2015. This contract was awarded on a firm-fixed price basis and did not utilize any set-aside designations. Life Technologies...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Life Technologies Corporation for $35,692.80. The contract calls for Life Technologies to deliver 80 units of heat inactivated fetal bovine serum with lot number 2661794P to the NIH Clinical Center in Bethesda, Maryland. The serum will support ongoing cell culture work and clinical research being performed by the Laboratory of Immunoregulation's HIV...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Gemini Bioproducts LLC for $15,006.97 on August 31, 2020, for benchmark fetal bovine serum, heat inactivated, 500 mL with a one-year storage option. Performance occurs in Broderick, California. The order is firm fixed-price with an ultimate completion date of February 27, 2021.</p>